Your browser is no longer supported. Please, upgrade your browser.
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.47 Insider Own0.10% Shs Outstand156.54M Perf Week-4.38%
Market Cap6.53B Forward P/E- EPS next Y-0.70 Insider Trans-77.37% Shs Float115.75M Perf Month0.17%
Income-225.20M PEG- EPS next Q-0.37 Inst Own98.70% Short Float7.96% Perf Quarter-6.19%
Sales393.10M P/S16.62 EPS this Y17.50% Inst Trans0.70% Short Ratio6.52 Perf Half Y-16.48%
Book/sh4.24 P/B9.68 EPS next Y59.80% ROA-29.50% Target Price59.33 Perf Year-3.46%
Cash/sh4.14 P/C9.92 EPS next 5Y25.00% ROE-33.50% 52W Range30.02 - 58.72 Perf YTD-4.07%
Dividend- P/FCF- EPS past 5Y-10.90% ROI-35.40% 52W High-30.11% Beta1.47
Dividend %- Quick Ratio8.40 Sales past 5Y390.00% Gross Margin94.80% 52W Low36.71% ATR1.38
Employees570 Current Ratio8.50 Sales Q/Q32.30% Oper. Margin-59.90% RSI (14)48.17 Volatility3.72% 3.11%
OptionableYes Debt/Eq0.00 EPS Q/Q29.30% Profit Margin-57.30% Rel Volume0.37 Prev Close41.21
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout- Avg Volume1.41M Price41.04
Recom1.70 SMA20-1.65% SMA502.38% SMA200-6.85% Volume528,279 Change-0.41%
Aug-25-20Initiated Raymond James Outperform $65
Aug-20-20Initiated Morgan Stanley Overweight $55
Jul-07-20Upgrade Stifel Hold → Buy $41 → $71
Apr-16-20Initiated Jefferies Buy $60
Mar-31-20Upgrade Goldman Neutral → Buy $45 → $72
Mar-06-20Initiated Citigroup Buy $69
Dec-16-19Initiated Guggenheim Buy $60
Oct-24-19Initiated Oppenheimer Perform $44
Oct-01-19Initiated RBC Capital Mkts Outperform $60
Sep-13-19Upgrade SVB Leerink Mkt Perform → Outperform
Sep-10-19Upgrade Canaccord Genuity Hold → Buy $29 → $50
Jul-23-19Reiterated Needham Buy $40 → $34
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-21-20 04:05PM  
Oct-14-20 04:05PM  
Oct-01-20 09:00AM  
Sep-07-20 05:15PM  
Sep-05-20 08:47AM  
Sep-04-20 11:31AM  
Sep-02-20 09:00AM  
Aug-31-20 09:00AM  
Aug-26-20 10:44PM  
Aug-25-20 09:35AM  
Aug-24-20 07:08AM  
Aug-23-20 11:33AM  
Aug-20-20 09:51AM  
Aug-12-20 09:00AM  
Aug-06-20 01:19PM  
Aug-05-20 06:25PM  
Jul-31-20 08:00PM  
Jul-30-20 03:37PM  
Jul-29-20 12:33PM  
Jul-28-20 11:33AM  
Jul-22-20 04:05PM  
Jul-21-20 04:24PM  
Jul-20-20 05:30PM  
Jul-12-20 08:54PM  
Jul-08-20 06:51AM  
Jul-07-20 10:42AM  
Jun-29-20 03:50PM  
Jun-17-20 07:36PM  
Jun-16-20 10:47AM  
Jun-15-20 09:00AM  
Jun-08-20 03:37AM  
Jun-06-20 11:31AM  
Jun-02-20 09:00AM  
May-28-20 09:00AM  
May-27-20 12:15PM  
May-26-20 09:00AM  
May-21-20 11:28PM  
May-09-20 08:02AM  
May-08-20 10:31PM  
May-07-20 06:10PM  
May-05-20 04:05PM  
Apr-30-20 12:34PM  
Apr-15-20 04:05PM  
Apr-13-20 09:43AM  
Mar-27-20 11:31AM  
Mar-24-20 04:23PM  
Mar-22-20 05:04PM  
Mar-20-20 02:11PM  
Mar-17-20 12:06AM  
Mar-03-20 05:50PM  
Feb-28-20 08:35PM  
Feb-27-20 11:13AM  
Feb-26-20 05:35PM  
Feb-24-20 09:00AM  
Feb-19-20 12:31PM  
Feb-12-20 09:00AM  
Feb-05-20 06:13AM  
Jan-29-20 05:00AM  
Jan-17-20 08:45AM  
Jan-10-20 11:54AM  
Jan-07-20 09:00AM  
Dec-23-19 02:47PM  
Dec-22-19 07:12AM  
Dec-19-19 10:18AM  
Dec-18-19 04:05PM  
Dec-17-19 09:11AM  
Dec-12-19 11:56AM  
Dec-11-19 09:04AM  
Dec-06-19 07:39AM  
Dec-05-19 11:01PM  
Dec-04-19 08:45PM  
Dec-02-19 02:57PM  
Dec-01-19 09:30AM  
Nov-27-19 10:00AM  
Nov-25-19 04:03PM  
Nov-21-19 09:56AM  
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YANG MICHAEL J.EVP and CCOOct 16Sale42.561,24753,0726,457Oct 19 05:27 PM
Stankovic Srdjan R.PresidentOct 16Sale42.561,29755,20013,006Oct 19 05:26 PM
DAVIS STEPHENCEOOct 16Sale42.562,960125,97814,786Oct 19 05:25 PM
YANG MICHAEL J.EVP and CCOJul 07Option Exercise23.0027,250626,77032,454Jul 09 06:26 PM
YANG MICHAEL J.EVP and CCOJul 07Sale56.2527,2501,532,7865,204Jul 09 06:26 PM
Stankovic Srdjan R.PresidentJun 19Option Exercise18.1216,452298,11027,786Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 19Sale50.1216,452824,51511,334Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Option Exercise18.8165,8431,238,69777,177Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Sale50.0165,8433,292,72911,334Jun 19 06:55 PM
DAVIS STEPHENCEOMay 14Option Exercise19.6588,5421,739,850100,351May 15 07:11 PM
DAVIS STEPHENCEOMay 14Sale45.6288,5424,039,10511,809May 15 07:11 PM
DAVIS STEPHENCEOMay 13Option Exercise19.65111,4582,190,150123,267May 15 07:11 PM
DAVIS STEPHENCEOMay 13Sale46.35111,4585,165,58711,809May 15 07:11 PM
Daly James MDirectorMay 11Option Exercise26.3926,250692,70026,250May 13 06:00 PM
Daly James MDirectorMay 11Sale51.1326,2501,342,1780May 13 06:00 PM
Stankovic Srdjan R.PresidentApr 30Sale49.214,308211,99711,334May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 30Sale49.221,05051,6812,195May 01 06:00 PM
DAVIS STEPHENCEOApr 30Sale49.216,770333,15211,809May 01 06:00 PM
YANG MICHAEL J.EVP and CCOApr 30Sale49.211,50173,8645,204May 01 06:00 PM
KIM AUSTIN D.EVP & General CounselApr 30Sale49.221,07252,7642,441May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Option Exercise25.1210,000251,20010,000May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Sale50.7410,000507,3530May 01 06:00 PM
Stankovic Srdjan R.PresidentApr 23Option Exercise20.6718,949391,70424,976Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 23Sale50.0718,949948,7296,027Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 22Option Exercise19.7754,0191,067,95660,046Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 22Sale50.0254,0192,701,9066,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Option Exercise19.65100,0001,965,000106,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Sale50.15100,0005,015,4506,027Apr 22 06:30 PM
BAKER BROS. ADVISORS LPDirectorMar 18Buy33.52135,8974,555,10138,433,977Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 17Buy32.84219,8007,218,90738,309,339Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 16Buy31.51694,30321,878,01738,107,749Mar 18 06:47 PM
Brege LauraDirectorJan 07Option Exercise1.7510,00017,50010,000Jan 08 06:01 PM
Brege LauraDirectorJan 07Sale42.1910,000421,9000Jan 08 06:01 PM
YANG MICHAEL J.EVP and CCODec 12Option Exercise31.09105,4793,279,377107,978Dec 13 05:35 PM
YANG MICHAEL J.EVP and CCODec 12Sale44.46105,4794,689,2632,499Dec 13 05:35 PM
KIM AUSTIN D.EVP & General CounselDec 11Option Exercise17.5817,500307,65018,009Dec 13 05:34 PM
KIM AUSTIN D.EVP & General CounselDec 11Sale45.0617,500788,576509Dec 13 05:34 PM
Ridloff ElenaEVP and CFODec 09Option Exercise15.8136,000569,16036,000Dec 11 06:29 PM
YANG MICHAEL J.EVP and CCODec 09Option Exercise35.8614,521520,72316,144Dec 11 06:30 PM
YANG MICHAEL J.EVP and CCODec 09Sale50.4614,521732,7921,623Dec 11 06:30 PM
Ridloff ElenaEVP and CFODec 09Sale49.6636,0001,787,8530Dec 11 06:29 PM
DAVIS STEPHENCEODec 05Option Exercise19.65150,0002,947,500152,954Dec 06 06:25 PM
DAVIS STEPHENCEODec 05Sale52.34150,0007,851,3002,954Dec 06 06:25 PM
Stankovic Srdjan R.PresidentNov 19Sale46.412,160100,2466,027Nov 21 05:37 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.